The suffering in Kenya has increased among those with HIV after the distribution of vaccines provided by the American Agency for International Development.
Stopping distribution causes supplies to hospitals that provide care for the injured, and obtaining treatment requires a lot of time.
Kenya is classified as the seventh country in the world in terms of those carrying this virus, Noufak for the World Health Organization, as there are 1.4 million infected people.
The United States was providing treatment for about 40% of the injured in Kenya through the “American President’s Emergency Plan of AIDS”, but after President Trump’s decision to suspend external aid 90 days the work stopped in many centers, and patients could no longer receive the necessary doses in the same way as they previously used to.
A health sector official, Reuters, said that the stock of two important drugs to treat HIV has decreased dramatically.
According to statements of relief and assistance of patients, some of the injured are almost a single dose per week.
Although there is a $ 34 million medicines in Kenya medicines and medical supplies, officials in Washington have not authorized the release of the funds required to distribute them.
The treatments stored in the American warehouse include 2.5 million vaccine boxes, 750,000 detections of the virus, and 500,000 doses for malaria treatment.
The government in Kenya submitted a request to the US Agency for International Development to lift the comment on AIDS treatment, but it did not find approval.
Government plan
Kenya’s Minister of Health said that she had set the required resources, and expects the government to mobilize money to provide urgent supplies within two weeks or more.
The Kenyan Government Authority concerned with diseases and epidemics said that the reduction in US aid left financing gaps estimated at 80 million dollars.
In his remarks before the Senate last week, Finance Minister John Malawadi said that the government is working on reviews on whether it will allocate urgent financing to compensate for US aid discounts before submitting the 2025-2026 budget.
The Kenyan government is working with some external organizations and partners, to overcome the acute shortage of medicines caused by the suspension of American aid.